4
Changes in Ownership
Certara, Inc. Filed Acc 0001415889-24-010291
PRESIDENT, DRUG DEV SOLUTIONS sold 14,427 shares at an average $16.85 ($243,161)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | 2024-04-02 | Sale 10b5-1 | −5,264 | $16.76 | $88,225 | 59,254 | D |
| SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | 2024-04-02 | Sale 10b5-1 | −649 | $17.72 | $11,500 | 58,605 | D |
| SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | 2024-04-02 | Sale 10b5-1 | −3,024 | $16.75 | $50,652 | 55,581 | D |
| SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | 2024-04-02 | Sale 10b5-1 | −328 | $17.67 | $5,796 | 55,253 | D |
| SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | 2024-04-02 | Sale 10b5-1 | −4,740 | $16.77 | $79,490 | 50,513 | D |
| SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | 2024-04-02 | Sale 10b5-1 | −422 | $17.77 | $7,499 | 50,091 | D |
| Open-market sales · 14,427 sh · avg $16.85 · $243,161 | |||||||
Loading xslF345X05/form4-04042024_080424.xml…